Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cannabix TechnologiesSTU:8CT +1.86%40 10-Year ROIIC % is 92.44 as of Apr. 2025. GuruFocus rates STU:8CT with a GF Score™ of 40/100. The stock has 2 warning signs investors should review. Among 692 Medical Devices & Instruments companies, Cannabix Technologies ranks better than 93.06% on this metric.
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
Cannabix Technologies's 10-Year ROIIC % for the quarter that ended in Apr. 2025 was 92.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Cannabix Technologies's 10-Year ROIIC % or its related term are showing as below:
STU:8CT's 10-Year ROIIC % is ranked better than 93.06% of 692
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs STU:8CT: 92.44
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Cannabix Technologies 10-Year ROIIC % Related Terms
Cannabix Technologies 10-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Cannabix Technologies's 10-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:8CT vs ABT, SYK, MDT: 10-Year ROIIC % Comparison
For the Medical Devices subindustry, Cannabix Technologies's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabix Technologies 10-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Cannabix Technologies's 10-Year ROIIC % falls into.
Cannabix Technologies's 10-Year ROIIC % for the quarter that ended in Apr. 2025 is calculated as:
10-Year ROIIC %
=
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( -3.027 (Apr. 2025) - -1.27 (Apr. 2015) )
/
( 0.287 (Apr. 2025) - 2.816 (Apr. 2015) )
=
-1.757
/
-2.529
=
69.47%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Cannabix Technologies (STU:8CT) has a 10-Year ROIIC % of 92.44 as of Apr. 2025. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Cannabix Technologies and its competitors. According to the industry distribution chart, Cannabix Technologies ranks #48 out of 692 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is Cannabix Technologies' 10-Year ROIIC % too high?
Cannabix Technologies' current 10-Year ROIIC % is 92.44. The Medical Devices & Instruments industry median 10-Year ROIIC % is 2.31. Cannabix Technologies' value of 92.44 is 3901.7% above this industry median. Based on the distribution chart, Cannabix Technologies ranks #48 out of 692 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Cannabix Technologies has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Cannabix Technologies' 10-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cannabix Technologies ranks #48 out of 692 companies for 10-Year ROIIC %. This places Cannabix Technologies in the top 7% of its industry — outperforming the majority of peers. The industry median 10-Year ROIIC % is 2.31. Cannabix Technologies' value of 92.44 is 3901.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 10-Year ROIIC % for a Medical Devices & Instruments company?
The median 10-Year ROIIC % among Medical Devices & Instruments companies is 2.31, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a 10-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 10-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabix Technologies's current 10-Year ROIIC % of 92.44 is 3901.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 10-Year ROIIC % mean?
A high 10-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 10-Year ROIIC % measures the change in earnings as a percentage of change in investment over 10-year. View historical data on Cannabix Technologies and its competitors. For the Medical Devices & Instruments industry, the median 10-Year ROIIC % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabix Technologies's current 10-Year ROIIC % is 92.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabix Technologies stock overvalued right now?
Cannabix Technologies (STU:8CT) has a current 10-Year ROIIC % of 92.44. The current 10-Year ROIIC % is 92.44 and 3901.7% above the Medical Devices & Instruments industry median of 2.31. Cannabix Technologies' overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 10-Year ROIIC % calculated?
10-Year ROIIC % is calculated from a company's financial statements. For Cannabix Technologies (STU:8CT), the current 10-Year ROIIC % is 92.44 as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabix Technologies Inc is engaged in the development of marijuana and alcohol breath testing technologies. Its products are Cannabix Marijuana Breath Test and BreathLogix Alcohol Breathalyzer.
40GF Score
Get the complete analysis for STU:8CT
10-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:8CT has been successfully added to your 
